These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17508987)

  • 1. Effect of cannabinoids on platelet serotonin uptake.
    Velenovská M; Fisar Z
    Addict Biol; 2007 Jun; 12(2):158-66. PubMed ID: 17508987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of monoamine oxidase activity by cannabinoids.
    Fisar Z
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun; 381(6):563-72. PubMed ID: 20401651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide.
    Pertwee RG; Stevenson LA; Griffin G
    Br J Pharmacol; 1993 Dec; 110(4):1483-90. PubMed ID: 8306090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
    Shivachar AC
    Biochem Pharmacol; 2007 Jun; 73(12):2004-11. PubMed ID: 17445778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid-induced changes in respiration of brain mitochondria.
    Fišar Z; Singh N; Hroudová J
    Toxicol Lett; 2014 Nov; 231(1):62-71. PubMed ID: 25195527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do cannabinoids exhibit a tyramine-like effect?
    Ilayan E; Feliszek M; Malinowska B; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec; 386(12):1041-6. PubMed ID: 23900610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nigrostriatal denervation changes the effect of cannabinoids on subthalamic neuronal activity in rats.
    Morera-Herreras T; Ruiz-Ortega JA; Linazasoro G; Ugedo L
    Psychopharmacology (Berl); 2011 Mar; 214(2):379-89. PubMed ID: 20959968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of endogenous, phyto and synthetic cannabinoids on thrombogenesis and platelet activity.
    Grambow E; Strüder D; Klar E; Hinz B; Vollmar B
    Biofactors; 2016 Nov; 42(6):581-590. PubMed ID: 27151562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes.
    Kracke GR; Stoneking SP; Ball JM; Tilghman BM; Washington CC; Hotaling KA; Johnson JO; Tobias JD
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):285-93. PubMed ID: 17960365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-independent effects of natural cannabinoids in rat peritoneal mast cells in vitro.
    Bueb JL; Lambert DM; Tschirhart EJ
    Biochim Biophys Acta; 2001 Apr; 1538(2-3):252-9. PubMed ID: 11336796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonclassical and endogenous cannabinoids: effects on the ordering of brain membranes.
    Bloom AS; Edgemond WS; Moldvan JC
    Neurochem Res; 1997 May; 22(5):563-8. PubMed ID: 9131634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes.
    Wiley JL; Martin BR
    Chem Phys Lipids; 2002 Dec; 121(1-2):57-63. PubMed ID: 12505690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta.
    O'Sullivan SE; Kendall DA; Randall MD
    Eur J Pharmacol; 2005 Jan; 507(1-3):211-21. PubMed ID: 15659311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids inhibit noradrenergic and purinergic sympathetic cotransmission in the rat isolated mesenteric arterial bed.
    Pakdeechote P; Dunn WR; Ralevic V
    Br J Pharmacol; 2007 Nov; 152(5):725-33. PubMed ID: 17641668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture.
    Kim D; Thayer SA
    J Neurosci; 2001 May; 21(10):RC146. PubMed ID: 11319244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices.
    Ameri A; Wilhelm A; Simmet T
    Br J Pharmacol; 1999 Apr; 126(8):1831-9. PubMed ID: 10372827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol.
    Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA
    Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
    Di Marzo V; Berrendero F; Bisogno T; González S; Cavaliere P; Romero J; Cebeira M; Ramos JA; Fernández-Ruiz JJ
    J Neurochem; 2000 Apr; 74(4):1627-35. PubMed ID: 10737621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells.
    Nilsson O; Fowler CJ; Jacobsson SO
    Eur J Pharmacol; 2006 Oct; 547(1-3):165-73. PubMed ID: 16928371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain.
    Nicholson RA; Liao C; Zheng J; David LS; Coyne L; Errington AC; Singh G; Lees G
    Brain Res; 2003 Jul; 978(1-2):194-204. PubMed ID: 12834914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.